Locally Advanced Lung Cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who received carbon ion radiotherapy for locally advanced lung cancer between September 1, 2025, and March 31, 2028
Exclusion criteria
Exclusion criteria: If the research subject or their representative refuses the use of their data for this research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse reaction occurring in the heart, lungs, and esophagus within 24 months after Carbon ion Radiotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival period, local control period, and progression free survival period | — |
Countries
Japan
Contacts
QST Hospital, National Institute for Quantum and Radiological Sciences and Technology Department of Diagnostic Radiology and Radiation Oncology